Export value of human vaccines from China 2017-2022
In 2022, China exported 6.45 billion yuan worths of human vaccines, representing a significant drop of almost 95 billion yuan from the previous year.
Impacted by the COVID-19 pandemic, the demand for Chinese-made vaccines increased significantly. In 2021, China exported more than 100 billion worth of human vaccines, representing an increase of more than 52000 percent from the previous year. Although with lower efficacy, Chinese COVID-19 vaccines manufactured by Sinovac, Sinopharm, and CanSino were widely adopted around the world, mostly in developing nations.
Impacted by the COVID-19 pandemic, the demand for Chinese-made vaccines increased significantly. In 2021, China exported more than 100 billion worth of human vaccines, representing an increase of more than 52000 percent from the previous year. Although with lower efficacy, Chinese COVID-19 vaccines manufactured by Sinovac, Sinopharm, and CanSino were widely adopted around the world, mostly in developing nations.
